CNSX:PLUSPLUS Products Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding PLUS Products Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $0.90 -0.11 (-10.89 %) (As of 05/29/2020 04:00 PM ET) Add Compare Share Today's Range$0.86Now: $0.90▼$1.0150-Day Range$0.52MA: $0.69▼$1.0152-Week Range N/AVolume64,122 shsAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileAnalyst RatingsAdvanced ChartCompetitorsHeadlinesOptions Chain Plus Products Inc. manufactures cannabis products in California. It offers cannabis-infused edibles to the regulated medicinal and adult-use, or recreational markets. The company also provides gummies in Nevada market. It sells products under the PLUS brand to dispensaries and delivery service customers. The company was incorporated in 2018 and is headquartered in Vancouver, Canada.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for PLUS Products. Previous Next 2.9 Community Rank Outperform VotesPLUS Products has received 23 “outperform” votes. (Add your “outperform” vote.)Underperform VotesPLUS Products has received 17 “underperform” votes. (Add your “underperform” vote.)Community SentimentPLUS Products has received 57.50% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about PLUS Products and other stocks. Vote “Outperform” if you believe PLUS will outperform the S&P 500 over the long term. Vote “Underperform” if you believe PLUS will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldPLUS Products does not currently pay a dividend.Dividend GrowthPLUS Products does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, PLUS Products insiders have not sold or bought any company stock. Previous Next 0.0 Earnings and Valuation Previous Next Analyst Opinion: 0.0Community Rank: 2.9Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.58 out of 5 stars Industry, Sector and Symbol Stock Exchange CNSX Industry Pharmaceuticals: Other Sub-IndustryN/A SectorMedical Current SymbolCNSX:PLUS Previous Symbol CUSIPN/A CIKN/A Webwww.plusproductsinc.com Phone+1 213.282.6987Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding SharesN/AMarket CapN/A Next Earnings DateN/A OptionableOptionable TSXV:PLUS Rates by TradingView Receive PLUS News and Ratings via Email Sign-up to receive the latest news and ratings for PLUS and its competitors with MarketBeat's FREE daily newsletter. PLUS Products (CNSX:PLUS) Frequently Asked Questions Has PLUS Products been receiving favorable news coverage? Press coverage about PLUS stock has been trending positive this week, InfoTrie Sentiment reports. The research firm identifies negative and positive press coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. PLUS Products earned a news sentiment score of 2.8 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an effect on the company's share price in the immediate future. View the latest news aboutPLUS Products. Who are some of PLUS Products' key competitors? Some companies that are related to PLUS Products include DAIICHI SANKYO/S (DSNKY), Medipharm Labs (MLCPF), ONO PHARMACEUTI/ADR (OPHLY), OTCMKTS:WDEXF (WDEXF) and Otsuka (OTSKF). View all competitors. What other stocks do shareholders of PLUS Products own? Based on aggregate information from My MarketBeat watchlists, some companies that other PLUS Products investors own include Curaleaf (CURLF), Sierra Oncology (SRRA), Aphria (APHA), Actinium Pharmaceuticals (ATNM), Co-Diagnostics (CODX), Tonix Pharmaceuticals (TNXP), Allena Pharmaceuticals (ALNA), BioRestorative Therapies (BRTX), Digital Ally (DGLY) and Ibio (IBIO). Who are PLUS Products' key executives? PLUS Products' management team includes the following people: Mr. Craig F. Heimark, Chairman, Chief Strategy Officer & Sec. (Age 64)Mr. Jacob F. Heimark, Co-Founder, CEO & DirectorMs. Jennifer Tung, Chief Risk OfficerMr. Justin Gwin, Co-Founder & Head of R&DMs. Lucie Herold, Co-Founder & Head of Sales What is PLUS Products' stock symbol? PLUS Products trades on the CNSX under the ticker symbol "PLUS." How do I buy shares of PLUS Products? Shares of PLUS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is PLUS Products' stock price today? One share of PLUS stock can currently be purchased for approximately $0.90. What is PLUS Products' official website? The official website for PLUS Products is www.plusproductsinc.com. How can I contact PLUS Products? The company can be reached via phone at +1 213.282.6987 or via email at [email protected] This page was last updated on 5/31/2020 by MarketBeat.com Staff
